Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, August 2, 2021 · 547,855,095 Articles · 3+ Million Readers

Parathyroid Hormone Industry Grows With Increase In Rate Of Osteoporosis Prevalence

Parathyroid Hormone Market Report 2021: COVID-19 Growth And Change To 2030

Parathyroid Hormone Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Parathyroid Hormone Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, June 11, 2021 /EINPresswire.com/ -- The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones. Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which further leads to an increased risk of fracture. According to the International Osteoporisis Foundation osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly. The parathyroid hormone, which is generally naturally produced by the body for regulating the calcium levels, is used to reduce the risk of bone fracture in people with osteoporosis and is administered as a daily subcutaneous injection. The increase in osteoporosis is therefore expected to contribute to the growth of the parathyroid hormone market.

The parathyroid hormone (PTH) market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders and partnerships) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body and is used in the treatment of diseases such as hypothyroidism and osteoporosis.

Read More On The Global Parathyroid Hormone Market Report:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-change

The global parathyroid hormone market is expected to grow from $1.72 billion in 2020 to $1.79 billion in 2021 at a compound annual growth rate (CAGR) of 4.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The parathyroid hormone market is expected to reach $2.02 billion in 2025 at a CAGR of 3%.

Major players with parathyroid hormone market shares are Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd., and Extend Biosciences Inc.

The parathyroid hormone global market covered in this report is segmented by disease type into hypocalcemia, hypoparathyroidism, by end-user into hospitals, clinics, other, and by product type into recombinant parathyroid hormone, parathyroid hormone analogues.

Parathyroid Hormone Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides parathyroid hormone market overview, forecast parathyroid hormone market size and growth for the whole market, parathyroid hormone market segments, and geographies, parathyroid hormone market trends, parathyroid hormone market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Parathyroid Hormone Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/biosimilar-hormones-global-market-report-2020-30-covid-19-growth-and-change

Corticosteroids Global Market Report 2021: COVID-19 Implications And Growth to 2030
https://www.thebusinessresearchcompany.com/report/corticosteroids-therapy-market-global-report-2020-2030-covid-19-implications-and-growth

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release